Clinical trialNCT00849563CompletedInterventional

Effect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes

SponsorDuke UniversityEnrollment450Diabetes Mellitus, Type 2

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary objective of the study is to assess the clinical utility of a genetic test for Type 2 diabetes risk in combination with standardized risk assessment compared with standardized risk assessment alone, and to measure whether changes in perceived risk following genetic testing for Type 2 diabetes risk are correlated with behavior change and increased concern about risk for Type 2 diabetes.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Alex Cho, MD
Institute for Genome Sciences and Policy, Duke University
Principal Investigator
clinicaltrials.gov ↗
Geoffrey Ginsburg, Md, PhD
Institute for Genome Sciences and Policy, Duke University
Principal Investigator
clinicaltrials.gov ↗
Gloria Trujillo, MD
Duke University
Principal Investigator
clinicaltrials.gov ↗
Isaac Lipkus, PhD
Institute for Genome Sciences and Policy, Duke University
Principal Investigator
clinicaltrials.gov ↗
Julianne O'Daniel, PhD
Institute for Genome Sciences and Policy, Duke University
Principal Investigator
clinicaltrials.gov ↗
Scott Joy, MD
Duke University
Principal Investigator
clinicaltrials.gov ↗
Susanne Haga, PhD
Institute for Genome Sciences and Policy, Duke University
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Duke Family Medicine at Pickens
Durham, North Carolina, United States
Duke Health Center at Pickett Rd
Durham, North Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Apr 2009
Primary completion: 30 Sept 2011
Completion: 30 Jun 2013
Last update posted: 10 Apr 2014
Registered enrollment: 450
Registry id: NCT00849563

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.